Financhill
Buy
58

UFPT Quote, Financials, Valuation and Earnings

Last price:
$266.82
Seasonality move :
11.87%
Day range:
$262.77 - $272.60
52-week range:
$178.26 - $289.57
Dividend yield:
0%
P/E ratio:
30.91x
P/S ratio:
3.47x
P/B ratio:
5.09x
Volume:
209.4K
Avg. volume:
159.5K
1-year change:
-1.94%
Market cap:
$2.1B
Revenue:
$504.4M
EPS (TTM):
$8.63

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
UFPT
UFP Technologies, Inc.
$149.1M $2.24 3.47% 6.38% $329.50
CATX
Perspective Therapeutics, Inc.
$231.1K -$0.35 -57.02% -40.33% $12.3077
INFU
InfuSystem Holdings, Inc.
$36.7M $0.05 8.36% 39.86% $14.20
ISRG
Intuitive Surgical, Inc.
$2.8B $2.27 15.98% 10.8% $608.26
MASI
Masimo Corp.
$408M $1.49 7.08% 565.51% $183.75
XTNT
Xtant Medical Holdings, Inc.
$30.8M -- -2.42% -100% $1.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
UFPT
UFP Technologies, Inc.
$266.65 $329.50 $2.1B 30.91x $0.00 0% 3.47x
CATX
Perspective Therapeutics, Inc.
$2.6700 $12.3077 $198.5M -- $0.00 0% 181.04x
INFU
InfuSystem Holdings, Inc.
$8.65 $14.20 $175.9M 33.08x $0.00 0% 1.30x
ISRG
Intuitive Surgical, Inc.
$525.81 $608.26 $186.4B 66.72x $0.00 0% 18.95x
MASI
Masimo Corp.
$143.93 $183.75 $7.7B 116.80x $0.00 0% 4.55x
XTNT
Xtant Medical Holdings, Inc.
$0.62 $1.50 $87.1M 60.99x $0.00 0% 0.68x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
UFPT
UFP Technologies, Inc.
29.07% 1.530 10.75% 1.27x
CATX
Perspective Therapeutics, Inc.
1.35% 3.042 1.3% 8.47x
INFU
InfuSystem Holdings, Inc.
30.8% 4.042 11.73% 1.35x
ISRG
Intuitive Surgical, Inc.
-- 1.051 -- 3.42x
MASI
Masimo Corp.
41.99% 0.887 7.4% 1.68x
XTNT
Xtant Medical Holdings, Inc.
39.2% 3.120 35.76% 1.08x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
UFPT
UFP Technologies, Inc.
$42.7M $23.7M 11.98% 18.42% 15.32% $32.5M
CATX
Perspective Therapeutics, Inc.
-$566K -$27.9M -37.13% -37.63% -13330.62% -$18.3M
INFU
InfuSystem Holdings, Inc.
$20.3M $3.8M 6.43% 9.93% 10.45% $8.4M
ISRG
Intuitive Surgical, Inc.
$1.9B $864.3M 16.57% 16.59% 30.16% $735.6M
MASI
Masimo Corp.
$230.6M $83.7M -11.41% -19.18% 22.53% $49.7M
XTNT
Xtant Medical Holdings, Inc.
$22M $2.5M 2.15% 3.78% 7.64% $4.2M

UFP Technologies, Inc. vs. Competitors

  • Which has Higher Returns UFPT or CATX?

    Perspective Therapeutics, Inc. has a net margin of 10.6% compared to UFP Technologies, Inc.'s net margin of -12425.36%. UFP Technologies, Inc.'s return on equity of 18.42% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.

    Company Gross Margin Earnings Per Share Invested Capital
    UFPT
    UFP Technologies, Inc.
    27.66% $2.11 $569.4M
    CATX
    Perspective Therapeutics, Inc.
    -270.81% -$0.35 $245.5M
  • What do Analysts Say About UFPT or CATX?

    UFP Technologies, Inc. has a consensus price target of $329.50, signalling upside risk potential of 23.57%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 360.96%. Given that Perspective Therapeutics, Inc. has higher upside potential than UFP Technologies, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than UFP Technologies, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    UFPT
    UFP Technologies, Inc.
    1 2 0
    CATX
    Perspective Therapeutics, Inc.
    12 1 0
  • Is UFPT or CATX More Risky?

    UFP Technologies, Inc. has a beta of 1.109, which suggesting that the stock is 10.859% more volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.182, suggesting its more volatile than the S&P 500 by 18.151%.

  • Which is a Better Dividend Stock UFPT or CATX?

    UFP Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UFP Technologies, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios UFPT or CATX?

    UFP Technologies, Inc. quarterly revenues are $154.6M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. UFP Technologies, Inc.'s net income of $16.4M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, UFP Technologies, Inc.'s price-to-earnings ratio is 30.91x while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UFP Technologies, Inc. is 3.47x versus 181.04x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    UFPT
    UFP Technologies, Inc.
    3.47x 30.91x $154.6M $16.4M
    CATX
    Perspective Therapeutics, Inc.
    181.04x -- $209K -$26M
  • Which has Higher Returns UFPT or INFU?

    InfuSystem Holdings, Inc. has a net margin of 10.6% compared to UFP Technologies, Inc.'s net margin of 6.19%. UFP Technologies, Inc.'s return on equity of 18.42% beat InfuSystem Holdings, Inc.'s return on equity of 9.93%.

    Company Gross Margin Earnings Per Share Invested Capital
    UFPT
    UFP Technologies, Inc.
    27.66% $2.11 $569.4M
    INFU
    InfuSystem Holdings, Inc.
    55.65% $0.11 $80.2M
  • What do Analysts Say About UFPT or INFU?

    UFP Technologies, Inc. has a consensus price target of $329.50, signalling upside risk potential of 23.57%. On the other hand InfuSystem Holdings, Inc. has an analysts' consensus of $14.20 which suggests that it could grow by 64.16%. Given that InfuSystem Holdings, Inc. has higher upside potential than UFP Technologies, Inc., analysts believe InfuSystem Holdings, Inc. is more attractive than UFP Technologies, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    UFPT
    UFP Technologies, Inc.
    1 2 0
    INFU
    InfuSystem Holdings, Inc.
    5 0 0
  • Is UFPT or INFU More Risky?

    UFP Technologies, Inc. has a beta of 1.109, which suggesting that the stock is 10.859% more volatile than S&P 500. In comparison InfuSystem Holdings, Inc. has a beta of 1.680, suggesting its more volatile than the S&P 500 by 68.01%.

  • Which is a Better Dividend Stock UFPT or INFU?

    UFP Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfuSystem Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UFP Technologies, Inc. pays -- of its earnings as a dividend. InfuSystem Holdings, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios UFPT or INFU?

    UFP Technologies, Inc. quarterly revenues are $154.6M, which are larger than InfuSystem Holdings, Inc. quarterly revenues of $36.5M. UFP Technologies, Inc.'s net income of $16.4M is higher than InfuSystem Holdings, Inc.'s net income of $2.3M. Notably, UFP Technologies, Inc.'s price-to-earnings ratio is 30.91x while InfuSystem Holdings, Inc.'s PE ratio is 33.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UFP Technologies, Inc. is 3.47x versus 1.30x for InfuSystem Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    UFPT
    UFP Technologies, Inc.
    3.47x 30.91x $154.6M $16.4M
    INFU
    InfuSystem Holdings, Inc.
    1.30x 33.08x $36.5M $2.3M
  • Which has Higher Returns UFPT or ISRG?

    Intuitive Surgical, Inc. has a net margin of 10.6% compared to UFP Technologies, Inc.'s net margin of 27.89%. UFP Technologies, Inc.'s return on equity of 18.42% beat Intuitive Surgical, Inc.'s return on equity of 16.59%.

    Company Gross Margin Earnings Per Share Invested Capital
    UFPT
    UFP Technologies, Inc.
    27.66% $2.11 $569.4M
    ISRG
    Intuitive Surgical, Inc.
    66.56% $2.21 $17.9B
  • What do Analysts Say About UFPT or ISRG?

    UFP Technologies, Inc. has a consensus price target of $329.50, signalling upside risk potential of 23.57%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $608.26 which suggests that it could grow by 15.68%. Given that UFP Technologies, Inc. has higher upside potential than Intuitive Surgical, Inc., analysts believe UFP Technologies, Inc. is more attractive than Intuitive Surgical, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    UFPT
    UFP Technologies, Inc.
    1 2 0
    ISRG
    Intuitive Surgical, Inc.
    14 11 1
  • Is UFPT or ISRG More Risky?

    UFP Technologies, Inc. has a beta of 1.109, which suggesting that the stock is 10.859% more volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.669, suggesting its more volatile than the S&P 500 by 66.867%.

  • Which is a Better Dividend Stock UFPT or ISRG?

    UFP Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UFP Technologies, Inc. pays -- of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios UFPT or ISRG?

    UFP Technologies, Inc. quarterly revenues are $154.6M, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.9B. UFP Technologies, Inc.'s net income of $16.4M is lower than Intuitive Surgical, Inc.'s net income of $799.5M. Notably, UFP Technologies, Inc.'s price-to-earnings ratio is 30.91x while Intuitive Surgical, Inc.'s PE ratio is 66.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UFP Technologies, Inc. is 3.47x versus 18.95x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    UFPT
    UFP Technologies, Inc.
    3.47x 30.91x $154.6M $16.4M
    ISRG
    Intuitive Surgical, Inc.
    18.95x 66.72x $2.9B $799.5M
  • Which has Higher Returns UFPT or MASI?

    Masimo Corp. has a net margin of 10.6% compared to UFP Technologies, Inc.'s net margin of 14.46%. UFP Technologies, Inc.'s return on equity of 18.42% beat Masimo Corp.'s return on equity of -19.18%.

    Company Gross Margin Earnings Per Share Invested Capital
    UFPT
    UFP Technologies, Inc.
    27.66% $2.11 $569.4M
    MASI
    Masimo Corp.
    62.07% -$1.86 $1.4B
  • What do Analysts Say About UFPT or MASI?

    UFP Technologies, Inc. has a consensus price target of $329.50, signalling upside risk potential of 23.57%. On the other hand Masimo Corp. has an analysts' consensus of $183.75 which suggests that it could grow by 27.67%. Given that Masimo Corp. has higher upside potential than UFP Technologies, Inc., analysts believe Masimo Corp. is more attractive than UFP Technologies, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    UFPT
    UFP Technologies, Inc.
    1 2 0
    MASI
    Masimo Corp.
    4 3 0
  • Is UFPT or MASI More Risky?

    UFP Technologies, Inc. has a beta of 1.109, which suggesting that the stock is 10.859% more volatile than S&P 500. In comparison Masimo Corp. has a beta of 1.263, suggesting its more volatile than the S&P 500 by 26.337%.

  • Which is a Better Dividend Stock UFPT or MASI?

    UFP Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Masimo Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UFP Technologies, Inc. pays -- of its earnings as a dividend. Masimo Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios UFPT or MASI?

    UFP Technologies, Inc. quarterly revenues are $154.6M, which are smaller than Masimo Corp. quarterly revenues of $371.5M. UFP Technologies, Inc.'s net income of $16.4M is lower than Masimo Corp.'s net income of $53.7M. Notably, UFP Technologies, Inc.'s price-to-earnings ratio is 30.91x while Masimo Corp.'s PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UFP Technologies, Inc. is 3.47x versus 4.55x for Masimo Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    UFPT
    UFP Technologies, Inc.
    3.47x 30.91x $154.6M $16.4M
    MASI
    Masimo Corp.
    4.55x 116.80x $371.5M $53.7M
  • Which has Higher Returns UFPT or XTNT?

    Xtant Medical Holdings, Inc. has a net margin of 10.6% compared to UFP Technologies, Inc.'s net margin of 3.93%. UFP Technologies, Inc.'s return on equity of 18.42% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.

    Company Gross Margin Earnings Per Share Invested Capital
    UFPT
    UFP Technologies, Inc.
    27.66% $2.11 $569.4M
    XTNT
    Xtant Medical Holdings, Inc.
    66.13% $0.01 $82.9M
  • What do Analysts Say About UFPT or XTNT?

    UFP Technologies, Inc. has a consensus price target of $329.50, signalling upside risk potential of 23.57%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 141.12%. Given that Xtant Medical Holdings, Inc. has higher upside potential than UFP Technologies, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than UFP Technologies, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    UFPT
    UFP Technologies, Inc.
    1 2 0
    XTNT
    Xtant Medical Holdings, Inc.
    2 0 0
  • Is UFPT or XTNT More Risky?

    UFP Technologies, Inc. has a beta of 1.109, which suggesting that the stock is 10.859% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.077, suggesting its less volatile than the S&P 500 by 107.701%.

  • Which is a Better Dividend Stock UFPT or XTNT?

    UFP Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UFP Technologies, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios UFPT or XTNT?

    UFP Technologies, Inc. quarterly revenues are $154.6M, which are larger than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. UFP Technologies, Inc.'s net income of $16.4M is higher than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, UFP Technologies, Inc.'s price-to-earnings ratio is 30.91x while Xtant Medical Holdings, Inc.'s PE ratio is 60.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UFP Technologies, Inc. is 3.47x versus 0.68x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    UFPT
    UFP Technologies, Inc.
    3.47x 30.91x $154.6M $16.4M
    XTNT
    Xtant Medical Holdings, Inc.
    0.68x 60.99x $33.3M $1.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoundHound AI Stock Go Up?
Why Did SoundHound AI Stock Go Up?

SoundHound AI (NASDAQ:SOUN) has moved higher in recent days, breaking…

Is Goldman Sachs Going to Go Up?
Is Goldman Sachs Going to Go Up?

Shares of financial giant Goldman Sachs (NYSE:GS) have soared by…

How High Will MSTR Stock Go?
How High Will MSTR Stock Go?

After several months of pressure, shares of Bitcoin treasury Strategy…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Sell
48
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
59
RGC alert for Jan 23

Regencell Bioscience Holdings Ltd. [RGC] is up 40.39% over the past day.

Buy
70
BNR alert for Jan 23

Burning Rock Biotech Ltd. [BNR] is up 33.29% over the past day.

Buy
76
HYMC alert for Jan 23

Hycroft Mining Holding Corp. [HYMC] is up 17.39% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock